InvestorsHub Logo
icon url

yellow_bluff

05/30/13 5:16 PM

#7640 RE: DewDiligence #7637

But by the time AZN finally gets the sNDA in for Epanova and finally gets approved and then also does a combo study for Epanova/Crestor and gets an NDA there approved, Crestor will also have gone over the cliff.
icon url

smarterer

05/31/13 3:06 PM

#7715 RE: DewDiligence #7637

You're making my point, Dew. A company with no statins under patents could take advantage of statins coming off patent, put them into a combo with Vascepa, and voila!, a new patentable drug combo, potentially. Lipitor is out of protection, Crestor is rolling off in a couple years. Other statins are in the same position.

AZN and others could suddenly find themselves trying to market a generic statin against its patented and more efficacious statin-Vascepa combo pill.